Business Paid
The Polish startup tries to recreate a cancer drug
18:27
A generic drug may change cancer treatment. The Polish Auxilius announces the drug's debut in the United States by 2025. The oncological drug on which the Polish company is working works on rare cancer that affects approx. 50,000 people in the US and Europe.
"Applied at an early stage, in many cases, it inhibits the development of the disease and excludes the need for further onerous treatment, such as chemotherapy.
This article is for subscribers
Warsaw Business Journal subscribers get the full archive (12,248 articles going back to 1995) and the print edition.
SubscribeOr try Poland A.M. free for 7 days, the daily briefing, or see all plans and prices.
